сега не штити од КОВИД-19 и спречува негово ширење.
имаш бројки да покажеш или само за шќиптарите кога беше муабетот, се расрфлаше со нецелосни бројки и тврдеше дека се факти, иако знаеше дека не ти се целосни.
Кога не беше законски да се носи, бројките беа двоцифрени, откако наметнаа, полетаа, ама штом кажувате дека спречува, мора да е така.
Опасна школа си ти (слушај ме што ти зборувам, не ме глеј што правам)
Врска вакцината против Бетмен:
Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults - Full Text View.
clinicaltrials.gov
Estimated Study Start Date: August 17, 2020
Estimated Primary Completion Date*: December 2, 2020
Estimated Study Completion Date: October 5, 2022 
*date when all volunteers have been recruited onto the trial.
1: To estimate the efficacy of 2 IM doses of AZD1222 compared to placebo for the prevention of COVID-19 in adults ≥ 18 years of age [Time Frame: 1 year]
A binary response, whereby a participant is defined as a COVID-19 case if their first case of SARS-CoV-2 RT-PCR-positive
symptomatic illness occurs ≥ 15 days post-second dose of the study intervention. Otherwise, a participant is
not defined as a COVID-19 case.
Значи:
a positive SARS-Cov-2 RT-PCR test is not sufficient to define someone as having been infected with the virus – they must also have symptoms 
William A. Haseltine, "небитен" е овој, Караџоски е тој што треба да го слушаме:
Several pharmaceutical companies have published their vaccine trial protocols. This unusually transparent action during a major drug trial deserves praise, close inspection of the protocols raises surprising concerns.
www.forbes.com
These trials seem designed to prove their vaccines work, even if the measured effects are minimal.
"These [vaccine] protocols do not emphasize the most important ramifications of COVID-19 that people are most interested in preventing: overall infection, hospitalization, and death."
[The COVID-19 vaccine trials are only looking to see if these vaccines reduce symptoms that may be as mild as cough and headache. They are NOT requiring that the vaccines reduce the risk of infection, hospitalization, or death.]
"It boggles the mind and defies common sense that the National Institute of Health, the Center for Disease Control, the National Institute of Allergy and Infectious Disease, and the rest would consider the approval of a vaccine that would be distributed to hundreds of millions on such slender threads of success."